Reaction
Acute Myelomonocytic Leukaemia reporting signals
As of the last recalculation, Acute Myelomonocytic Leukaemia appears in 250 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is BLEOMYCIN SULFATE (PRR 137.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bleomycin Sulfate | 16 | 137.7 | 137.9 |
| Blinatumomab | 6 | 49.0 | 49.1 |
| Vincristine Sulfate | 15 | 45.3 | 45.3 |
| Etoposide | 32 | 41.4 | 41.4 |
| Azacitidine For | 8 | 37.8 | 37.8 |
| Azacitidine | 10 | 29.2 | 29.2 |
| Lutetium Lu 177 Vipivotide Tetraxetan | 3 | 19.2 | 19.2 |